Definitions
Sorry, no definitions found. You may find more data at pixantrone.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Pixantrone.
Examples
-
Pixantrone is a next-generation anthracycline designed to be more effective and less toxic, allowing patients to continue therapy for longer.
-
Pixantrone was overwhelmingly rejected by the FDA advisory committee at the outset primarily because of the small number of patients treated in the study only eight in the U.S., 140 total and over safety concerns present with the drug when compared to the control.
-
Pixantrone is targeted to patients with aggressive non-Hodgkin's lymphoma who have already received two or more chemotherapy treatments.
-
Cell Therapeutics: Pixantrone data assessment shows 'significant results' Follow this company said a second assessment of data from a clinical trial of its pixantrone cancer drug reported "significant results."
unknown title 2011
-
Cell Therapeutics: Pixantrone data assessment shows 'significant results' KirstenGrind: Check out our great slideshow of Wall Street protests, via @ #OccupyWallStreet
unknown title 2011
-
Slide show: Billionaire Sean Parker throws monster party for Spotify Cell Therapeutics: Pixantrone data assessment shows 'significant results' on Thursday, September 29th
unknown title 2011
-
According to Cell Therapeutics, "Pixantrone is a novel aza-anthracenedione that has distinct structural and physio-chemical properties that make its anti-tumor activity unique in this class of agents."
unknown title 2011
-
The company's headline drug, Pixantrone was rejected by the FDA and now the stock trades close to 52 week lows.
unknown title 2011
-
MAA review for EU approval of Pixantrone on track for potential 4th quarter recommendation by CHMP
unknown title 2011
-
CTI Reports Reduction in Operating Expenses and Net Losses for Second Quarter and First Half 2011 Compared to 2010, and Advances In Bringing Pixantrone to Market - FDA appeal guidance allows CTI to resubmit pixantrone NDA in 4th quarter with no new clinical trials in advance of potential accelerated approval
unknown title 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.